BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,071 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $49,894,488 | -2.6% | 1,491,614 | +24.5% | 0.85% | -0.8% |
Q1 2024 | $51,217,094 | +8.7% | 1,198,341 | -1.7% | 0.86% | +1.3% |
Q4 2023 | $47,135,702 | +16.9% | 1,219,237 | +14.1% | 0.84% | +3.8% |
Q3 2023 | $40,328,964 | +13.2% | 1,068,600 | +36.7% | 0.81% | +15.6% |
Q2 2023 | $35,618,125 | +3.7% | 781,785 | -7.7% | 0.70% | -10.0% |
Q1 2023 | $34,343,166 | +110.7% | 846,725 | +164.7% | 0.78% | +106.1% |
Q4 2022 | $16,303,213 | +7.4% | 319,859 | +13.5% | 0.38% | -5.2% |
Q3 2022 | $15,182,000 | +14.0% | 281,875 | +36.0% | 0.40% | +24.2% |
Q2 2022 | $13,316,000 | -25.1% | 207,316 | -9.5% | 0.32% | -16.6% |
Q1 2022 | $17,767,000 | -5.9% | 229,136 | +4.2% | 0.39% | -5.4% |
Q4 2021 | $18,881,000 | +8.7% | 219,957 | +1.8% | 0.41% | +1.5% |
Q3 2021 | $17,373,000 | +10.2% | 215,997 | +10.3% | 0.40% | +10.4% |
Q2 2021 | $15,770,000 | +18.1% | 195,902 | +23.8% | 0.36% | -0.5% |
Q1 2021 | $13,348,000 | +6.9% | 158,269 | +1.7% | 0.37% | -12.6% |
Q4 2020 | $12,490,000 | +0.9% | 155,654 | +1.1% | 0.42% | -14.7% |
Q3 2020 | $12,383,000 | +19.9% | 153,977 | +28.4% | 0.49% | +15.5% |
Q2 2020 | $10,326,000 | +42.9% | 119,930 | +34.8% | 0.42% | +12.4% |
Q1 2020 | $7,226,000 | -2.9% | 89,000 | 0.0% | 0.38% | +28.6% |
Q4 2019 | $7,442,000 | +742.8% | 89,000 | +781.2% | 0.29% | +740.0% |
Q3 2019 | $883,000 | +21.1% | 10,100 | +13.5% | 0.04% | +29.6% |
Q2 2019 | $729,000 | +0.7% | 8,900 | 0.0% | 0.03% | +8.0% |
Q1 2019 | $724,000 | +23.5% | 8,900 | 0.0% | 0.02% | +19.0% |
Q4 2018 | $586,000 | -28.9% | 8,900 | -16.7% | 0.02% | -8.7% |
Q3 2018 | $824,000 | +25.4% | 10,686 | +20.1% | 0.02% | +21.1% |
Q2 2018 | $657,000 | +13.5% | 8,900 | 0.0% | 0.02% | +11.8% |
Q1 2018 | $579,000 | +0.7% | 8,900 | 0.0% | 0.02% | +6.2% |
Q4 2017 | $575,000 | -19.4% | 8,900 | -21.8% | 0.02% | -20.0% |
Q3 2017 | $713,000 | +3.5% | 11,375 | 0.0% | 0.02% | +5.3% |
Q2 2017 | $689,000 | +14.1% | 11,375 | -2.3% | 0.02% | +18.8% |
Q1 2017 | $604,000 | +19.6% | 11,640 | +2.3% | 0.02% | +14.3% |
Q4 2016 | $505,000 | -6.7% | 11,375 | 0.0% | 0.01% | -12.5% |
Q3 2016 | $541,000 | +11.1% | 11,375 | +5.7% | 0.02% | 0.0% |
Q2 2016 | $487,000 | +10.2% | 10,760 | 0.0% | 0.02% | +14.3% |
Q1 2016 | $442,000 | +30.0% | 10,760 | +20.9% | 0.01% | +55.6% |
Q4 2015 | $340,000 | +151.9% | 8,900 | +117.1% | 0.01% | +200.0% |
Q3 2015 | $135,000 | -51.8% | 4,100 | +2.5% | 0.00% | -50.0% |
Q2 2015 | $280,000 | – | 4,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |